newsfilter
← Latest News
Business Wire·

Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections

Collaboration to develop engineered bacteriophage therapeutics targeting bacterial pathogens responsible for serious eye infections Locus Biosciences, Inc. ("Locus"), a clinical-stage biotechnology company developing